Register for the MSHP Annual Meeting Oct. 25 in Grand Rapids

Join the Michigan Society of Health-System Pharmacists (MSHP) for its 2024 Annual Meeting at the Sheraton Grand Rapids Airport Hotel! The MSHP Annual Meeting offers continuing education for pharmacists, residents and pharmacy technicians, along with a chance for exhibitors and sponsors to showcase products and network with MSHP members. Student pharmacists are highly encouraged to attend and participate in all activities.

Registration is available now! Click the buttons below to get started.

Book Your Room for ACE 2025 Now!

Start planning for the Michigan Pharmacists Association (MPA) 2025 Annual Convention & Exposition April 11-13, 2025, at the Grand Traverse Resort and Spa just outside of Traverse City! Information on registration, exhibitors and sponsorship will become available later this year, but it's not too early to block off your calendars as pharmacy's biggest continuing education event in Michigan takes its show on the road. You can book your room now by clicking the button below.

MPA is encouraging guests to make ACE 2025 their Michigan "staycation." Whether it's a round of golf or exploring the sights and sounds of the beautiful Traverse City area, there are limitless activities at ACE 2025.

- BOARD UPDATE -

Less, Not Loss, for Our Well-Being

By Diana Kostoff, BSPharm, Pharm.D., BCPS, BCOP;

Henry Ford Health; MSHP director

In recent years, burnout, resilience and well-being have been at the forefront of our profession. The first-ever Health Workforce Well-Being Day of Awareness was on March 18. The American Society of Health-System Pharmacists (ASHP) was honored to join the National Academy of Medicine (NAM) and other partners to celebrate this day. ASHP launched its Well-Being Ambassador program in 2022 and has a Well-Being & You Resource Center along with podcasts and webinars dedicated to its commitment statement: “to foster and sustain the well-being, resilience and professional engagement of the pharmacy workforce.” 

In MSHP’s strategic plan, the objective is to promote member wellness and resilience beyond education. The organization strives to increase the number of wellness activities provided at MSHP meetings. 

I believe we can relate to MSHP President Kyle Schmidt’s 2024 theme of “Less, Not Loss” to well-being, since some of the concepts and core beliefs of essentialism may influence our professional and personal lives.

“The basic value proposition of essentialism: only once you give yourself permission to stop trying to do it all, to stop saying yes to everyone, can you make your highest contribution towards the things that really matter.”¹

There are several personality traits pharmacists have in common. One of the top five is responsibility, which forces us to take ownership of anything we commit to and follow it through to completion.² We are dependable; people look to us first because they know we will complete our responsibilities. Our willingness to volunteer may sometimes result in us taking on more than we should, leading to burnout and risking our well-being in the process.

“Multitasking itself is not the enemy of essentialism; pretending we can ’multi-focus’ is.” Essentialism is not doing only one thing at a time, but being focused on one thing at a time. The recommendation is to make two lists – ‘most important right now’ and ‘get the future out of your head ‘(future plans)’ and then prioritize both.¹

Pharmacists are known for multitasking skills, but we might fall victim to thinking we can multi-focus. When working on one task, we need to stay focused on that task. One simple way to start is to keep a daily to-do list that prioritizes what you want to accomplish for the day and focus on each bullet one at a time. I have done this in my entire career, which has helped with my well-being. Prioritization and focus will decrease your energy from being pulled into multiple directions, allow you to focus on the most essential things in your life and career, and ultimately improve your well-being.

From an organizational standpoint, focusing strategic objections and committee charges on what matters most – and what will achieve the highest contribution to the pharmacy profession – is essential. As an organization, MSHP must maintain its well-being and promote the well-being of its members and pharmacy practice. Even if the number of objectives and charges are less, they are focused on producing more value and thus, “not loss.”

References

1. McKeown G. Essentialism: The disciplined pursuit of less. New York, Crown Business, 2014.
2. Gilchrist A. Top 5 Pharmacist Personality Traits. Pharmacy Times, 2015.

- ANTIMICROBAL STEWARDSHIP -

Antibiotic Overprescribing in Sinusitis: Opportunities for Antimicrobial Stewardship?

By Christen J. Arena, Pharm.D. and Michael P. Veve, Pharm.D.,

MPH, Eugene Applebaum College of Pharmacy and Health Sciences,

Wayne State University and Henry Ford Hospital

Sinusitis is one of the top ambulatory diagnoses associated with antibiotic use, even though most cases are viral.¹ Of the 20 million presumed bacterial sinusitis cases that occur annually, nearly 82% result in an antibiotic prescription.^1-2 Putting this into context, 1 in 5 people who receive an antibiotic prescription will develop an unintended adverse event.³

Epidemiologic data suggest up to 98% of sinusitis has a viral etiology, not bacterial.⁴ Antibiotics are only indicated in patients with prolonged sinusitis symptoms (10 days or longer), such as nasal drainage, loss of smell and facial pressure.¹ Additionally, much of what is diagnosed as sinusitis is not infectious and represents symptoms from mimicking conditions, such as chronic allergic or nonallergic rhinitis, migraine or other headaches, or laryngopharyngeal reflux.¹

While sinusitis is a clear and logical target for ambulatory antimicrobial stewardship programs, several barriers make sinusitis stewardship challenging. Health-system resources for antimicrobial stewardship are generally prioritized towards inpatient settings, where there are personnel to provide prospective audits and feedback. The disconnect lies in that antimicrobial consumption in ambulatory settings completely dwarves inpatient use, where more than 270 million outpatient antibiotic prescriptions are generated each year, and up to 50% are unnecessary.⁵ Despite more opportunities for improvement in infectious disease states like sinusitis, successful stewardship interventions in outpatient settings are much less frequently described in peer-reviewed literature.

Ambulatory and community pharmacists can be excellent stewards of sinusitis. A first step in improving sinusitis prescribing is to review antibiotic use in your setting to identify specific opportunities for improvement. Without a doubt, there are challenges in convincing prescribers and patients when antibiotics are not indicated and can potentially cause harm. However, there is a slew of notable stewardship approaches that can be applied from acute care settings to optimize antibiotic use in the ambulatory arena:

• Educate and Share Prescribing Data. Provider and patient education is an essential foundational antimicrobial stewardship tool. Education has decreased antibiotic prescriptions for upper respiratory infections in the ambulatory space, although frequently with concomitant stewardship efforts.^6-7 Education alone may not change behavior, but it is still useful and should be considered. One educational mechanism could be to regularly share sinusitis prescribing data with primary care providers to show antibiotic use trends. The stewardship team can help facilitate these efforts and assist in process reviews or implement handshake stewardship to optimize antibiotic use. Action item: Work with your stewardship team to educate and routinely provide aggregate or individual prescribing data to your clinicians. 
• Leverage the Electronic Health Record. Antimicrobial stewardship interventions that leverage the electronic health record (EHR) allow for antibiotic optimization. Simple and low resource EHR stewardship efforts are effective, such as specific discharge order sets, order sentences and best practice advisories. The purpose is to implement a choice architecture that guides the prescriber towards a specific decision while preserving their autonomy and supporting their decision-making. Working with your health information technology specialists will help create and operationalize thoughtful and sustainable decision support interventions. Action item: Apply low-effort and high-yield antimicrobial stewardship interventions to the outpatient EHR to direct optimal antibiotic treatment.
• Partner with Ear-Nose-Throat Specialists. Diagnosing sinusitis can be optimized through a combination of patient symptoms and nasal endoscopy, where consultation with an ear-nose-throat (ENT) surgeon is preferred in patients with chronic, recurrent disease.¹ Identifying an appropriate ENT collaborator in your health system can help support future stewardship initiatives focused on improving sinusitis management, including primary care provider education. Having buy-in from the diagnostic expert gives your initiative credibility in the context of improving patient care. Action item: Identify an ENT champion and share sinusitis antibiotic use data with them. Future directions could include the involvement of ENT referrals as a component of patient care for chronic or recurrent sinusitis.
• Advocate for Sinusitis Antibiotic Use Metrics/Benchmarking. Health care providers are expected to manage patient care effectively and meet several health-system priority metrics, especially in ambulatory settings. While antibiotic prescribing performance-based metrics exist, such as health care effectiveness data and information set (HEDIS) or other local payer measures, they often exclude important stewardship initiatives. Collaborating with ambulatory provider leadership and developing valuable and meaningful local performance measures for disease states like sinusitis is a powerful mechanism to promote accountability. Alternatively, the stewardship team should lobby for state and national agencies to adopt more contemporary stewardship metrics into their ambulatory performance categories. Using internal prescribing data, some logical sinusitis metrics could be drug selection, optimal duration, or visits that did not generate an antibiotic prescription. Sharing performance or incentive-based stewardship metric data for sinusitis prescribing allows for a more meaningful approach to benchmarking that results in change.⁸ Action item: Advocate for sinusitis-based metrics that matter to the stewardship team and health-system leadership to create accountability.

References 

1. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1-S39. doi:10.1177/0194599815572097
2. Hersh AL, King LM, Shapiro DJ, Hicks LA, Fleming-Dutra KE. Unnecessary Antibiotic Prescribing in US Ambulatory Care Settings, 2010-2015. Clin Infect Dis. 2021;72(1):133-137. doi:10.1093/cid/ciaa667
3. Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of Adverse Events With Antibiotic Use in Hospitalized Patients. JAMA Intern Med. 2017;177(9):1308-1315. doi:10.1001/jamainternmed.2017.1938
4. Smith SS, Ference EH, Evans CT, Tan BK, Kern RC, Chandra RK. The prevalence of bacterial infection in acute rhinosinusitis: a Systematic review and meta-analysis. Laryngoscope. 2015;125(1):57-69. doi:10.1002/lary.24709
5. Measuring outpatient antibiotic prescribing. 2017. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/antibiotic-use/community/programs-measurement/measuring-antibiotic-prescribing.html. Accessed March 15, 2024.
6. Burns KW, Johnson KM, Pham SN, Egwuatu NE, Dumkow LE. Implementing outpatient antimicrobial stewardship in a primary care office through ambulatory care pharmacist-led audit and feedback. J Am Pharm Assoc. 2020;60(6):e246-e251
7. Davidson LE, Gentry EM, Priem JS, Kowalkowski M, Spencer MD. A multimodal intervention to decrease inappropriate outpatient antibiotic prescribing for upper respiratory tract infections in a large integrated healthcare system. Infect Control Hosp Epidemiol. 2023;44(3):392-399. doi:10.1017/ice.2022.83
8. Measurement and Evaluation Approaches to Improve Outpatient Antibiotic Prescribing in Health Systems. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/antibiotic-use/pdfs/measurement-evaluation-improve-outpatient-508.pdf. Accessed March 22, 2024.

- RESIDENT'S CORNER -

Enhancing Patient Safety: Understanding the Significance

of the 2023 Beers Criteria for Pharmacists

By Paige Hanke, Pharm.D., Cailyn Evan, Pharm.D., Sara Barakat, Pharm.D.

and Nataliya Sorochak, Pharm.D.

As the population ages, the importance of safe medication use in older adults becomes increasingly pronounced. With age-related changes in physiology and metabolism, older adults are more susceptible to adverse drug events. In response to this challenge, the American Geriatrics Society (AGS) has developed the Beers Criteria, a tool to improve the safety of medication use in older adults 65 and older. The tool is named after Mark Beers, a geriatrician who helped develop the first criteria in 1991.

A 12-member expert panel, including seven pharmacists, conducts comprehensive literature evaluations to provide updates to the criteria periodically. The recent 2023 update of the Beers Criteria is meant to provide health care providers with guidelines on identifying potentially inappropriate medications (PIMs) and encourage older adult-specific de-prescribing, patient education, renal dose adjustments and drug-drug interaction monitoring.

The 2023 Beers Criteria introduces structural and clinical updates by removing medications with low usage in the United States. Additionally, language about end-of-life and hospice settings are excluded from these recommendations. Clinically, the criteria emphasize cardiovascular, diabetes and fall-risk updates. Recommendations regarding cardiovascular care focus on the use of anticoagulants, particularly advising against warfarin and rivaroxaban in older adults due to increased bleeding risks. It also advises against aspirin for primary prevention of cardiovascular disease and raises caution with medications like ticagrelor and dextromethorphan/quinidine due to bleeding and QT prolongation risks.

For diabetes management, the criteria now advise against both short- and long-acting sulfonylureas in older adults as first-, second- or add-on therapy due to increased cardiovascular risks and hypoglycemia. They suggest using sodium-glucose cotransporter-2 inhibitors (SGLT2) with caution due to urogenital infections and euglycemic diabetic ketoacidosis risk. Furthermore, the updates stress careful monitoring for adverse drug events associated with these medications.

By adding gabapentinoids, skeletal muscle relaxants, and opioids to the list of agents to use cautiously, the updates also address medication-related risks for falls, fractures and delirium in older adults. This emphasizes the dangers associated with medications possessing anticholinergic and sedative properties and helps to reduce their use in this patient population. Additionally, they recommend avoiding three or more central nervous system-active agents at one time (such as antiepileptics, including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids and skeletal muscle relaxants). Moreover, the updated criteria highlight the risks associated with prolonged proton pump inhibitor use by adding pneumonia and gastrointestinal malignancies to the list of possible adverse effects and emphasizing deprescribing guidelines to counteract overuse. There is also guidance for adjusting medication dosing in older adults with renal impairment.

The 2023 Beers Criteria medication list is a valuable tool for pharmacists in enhancing patient safety, optimizing therapy and facilitating interprofessional collaboration. AGS has released a new app and pocket card for quick reference, which can be found on its website. By familiarizing themselves with the Beers Criteria and applying its recommendations in practice, pharmacists can play a pivotal role in ensuring the safe and effective use of medications in older adults, ultimately improving patient outcomes and quality of life.

References

1. 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society.

- ORGANIZATIONAL AFFAIRS -

Preview of the 2024 ASHP House of Delegates

By Rebecca S. Maynard, Pharm.D.

The American Society of Health-System Pharmacists (ASHP) will convene its 76th annual session of the House of Delegates in June at ASHP Pharmacy Futures 2024 in Portland, Oregon. The Michigan Society of Health-System Pharmacists’ (MSHP) elected delegates this year are Lama Hsaiky, Jesse Hogue, Jessica Jones and Becky Maynard. We will convene over multiple days to consider policy recommendations and statements, ASHP Board and Committee reports, and other Society business. 

During the second meeting of the House, we will elect the new chair of the House of Delegates (2024-2027), with Hogue, of Kalamazoo, and Martin J. Torres, of Orange, California, on the slate of candidates. The full 2024 slate of candidates can be found on the ASHP website. The updated report of the Committee on Nominations, including candidate biographies and statements, will be available on the ASHP website by mid-May. 

The MSHP delegates have already been hard at work this year, starting with the first virtual House of Delegates in March, where we considered 20 policy recommendations. Twelve policies reached the threshold of 85% for approval; the eight policy recommendations not approved will be further considered by the House in June. The report on the March virtual House and a summary slide set of the policies approved are available on the HOD website.

During this year’s Regional Delegate Conferences (RDCs), ASHP hosted nine in-person and virtual meetings over four days, with more than 200 delegates, Board members and ASHP staff participating in lively debate of policy amendments, as evidenced by the ASHP Connect discussion posts. Delegates are currently working to turn those in-depth conversations into policy amendment language. We have provided some brief updates on the topics that generated the most discussion.

There are multiple policies related to access. Last year, policies were mostly targeted at pharmacist prescriptive authority (Pharmacist Prescribing Authority for Antiretroviral Therapy for the Prevention of HIV/AIDS, Point-of-Care Testing and Treatment, Nonprescription Availability of Oseltamivir, Over-the-Counter Availability of Oral Contraceptives) to help us build evidence for broader efforts in the future. For 2024, a policy is under consideration to advocate that pharmacists have independent and autonomous authority to initiate, modify, monitor and deprescribe all schedules and classes of medications. In addition to the multiple policies that will be discussed at the House in June, the ASHP Statement on the Community Pharmacist’s Role in the Care Continuum will be voted on in the May virtual House, which our Michigan delegates supported.

Below is the full list of policies and statements pending for the House, with a few highlights. ASHP members can view the official language of the policy recommendations at the ASHP House of Delegates website. They can also follow online discussions via the House of Delegates community within ASHP Connect. We encourage you to review the proposed policies and contact one of the delegates with any questions or comments you may have: Lama Hsaiky (lama.hsaiky@corewellhealth.org), Jesse Hogue (hoguej@bronsonhg.org), Jessica Jones (jessica.jones2@corewellhealth.org) and Becky Maynard (maynardr@bronsonhg.org).

COUNCIL ON PHARMACY MANAGEMENT POLICY RECOMMENDATIONS

• Prehospital Management of Medications (voting in May virtual House)
• Role of Artificial Intelligence (AI) in Pharmacy Practices
• Expect amendments that align with a forward-thinking policy that encourages the safe use of AI that aids in ethical decision-making and the pharmacist’s professional judgment.
• Independent Prescribing Authority (not approved in March virtual House)
• Expect amendments to remove clauses that are covered in other ASHP policies (such as the role of the pharmacist and establishing credentialing and privileging process) and have one powerful advocacy clause for independent and autonomous prescribing authority.
• Pharmacist’s Role on Ethics Committees (not approved in March virtual House)
• Safe Handling and Administration of Hazardous Drugs (not approved in March virtual House)
• Much of the discussion in Connect and at RDCs is that pharmacies have to follow USP <800> Standards because of the risk of exposure, but there is not enough to prevent contamination before the hazardous drugs are received in the pharmacy.
• Expect amendments that focus on advocacy efforts for pharmaceutical manufacturers and the FDA to reduce surface contamination and require standardized labeling, and for pharmacist involvement in policy, procedure and operational assessments.

COUNCIL ON PUBLIC POLICY RECOMMENDATIONS

• Order Verification (not approved in March virtual House)
• Liability Protection (not approved in March virtual House)
• This policy is in response to civil and criminal liability for providing care related to services like reproductive health, gender-affirming care, and prevention of HIV. ○ Expect amendment that includes the intent as outlined in the Rationale to be pulled into the policy statement so the policy is not misinterpreted in its currently proposed broad state.
• State Prescription Drug Monitoring Programs (not approved in March virtual House)
• Update to 2014 policy that is being modified to focus on the need for full interstate data integration and allow full access for the pharmacy workforce in any state.

COUNCIL ON THERAPEUTICS POLICY RECOMMENDATIONS

• Testing for Pregnancy Status
• There is important information in the rationale for why this standalone policy would bridge a gap, and it would align ASHP policy with the American Society of Anesthesiologists’ statement.
• This would complement existing policy positions (Medication-Related Clinical Testing and Monitoring, Patient’s Right to Choose, and Pharmacoequity) and affirm that pregnancy testing should only occur with patient consent and when results would change medical management.
• F-HT2 Agonist, Entactogen and Empathogen (Psychedelic) Assisted Therapy
• With growing interest in psychedelic drugs for use in the treatment of conditions such as depression, PTSD, substance use disorders, etc., the Council recommended an additional policy for developing best practices and regulatory standards, along with inclusion of health care providers during psychedelic assisted therapy (PAT).
• This will build on a 2023 policy (2323) advocating for elimination of federal and state laws that create barriers to research on therapeutic use of Schedule I substances.
• Nonprescription Status of Rescue and Reversal Medications (not approved in March virtual House)
• This would broaden the scope of existing policies for nonprescription status of rescue and reversal medications (e.g. include epinephrine pens, albuterol inhaler).
• Expect amendment to clarify that it is for medications intended to be self-administered.

COUNCIL ON EDUCATION AND WORKFORCE DEVELOPMENT POLICY RECOMMENDATIONS

• Opposition to Pharmacy Jurisprudence Examination Requirement
• Michigan is one of three states that have eliminated the jurisprudence examination requirement. There was a lot of discussion about a positive impact on pharmacy residents and time to licensure, and for pharmacists practicing near state borders.
• Expect an amendment to ensure there is adequate initial and ongoing education of the pharmacy workforce on federal and state laws.
• Pharmacy Technician Education Requirements
• Update to a 2012 policy to increase focus on additional formalized training or advanced certification in advanced pharmacy technician roles.
• Implications of Artificial Intelligence for Professional Integrity
• Separate from the previous AI policy proposal, this focuses on maintaining academic integrity with the rapid advancement of generative AI technologies.
• Pharmacy Residency Training (not approved in March virtual House)

COUNCIL ON PHARMACY MANAGEMENT RECOMMENDATIONS

• Documentation of Patient-Care Services in the Permanent Health Record
• Supporting High Reliability in Pharmacy Practice (voting in May virtual House)
• Safe Medication Sourcing, Preparation and Administration in All Sites of Care

SECTION OF COMMUNITY PHARMACY PRACTITIONERS POLICY RECOMMENDATION

• ASHP Statement on the Community Pharmacist’s Role in the Care Continuum (voting in May virtual House)

- REGIONAL UPDATE -

Capital Area Pharmacists Association Update 

By Tim Ekola, BSPharm, Pharm.D., MBA, MSHP board liaison

2024 CAPA Presidential Address – Todd Belding, Pharm.D.

Thank you for the privilege of representing the Capital Area Pharmacists Association (CAPA). As a member of MPA and CAPA for nearly 15 years, I'm excited about the chance to serve as president. My involvement in CAPA has varied over the years due to changes in my home, school and work life. In the face of the new normal, this year presents a valuable opportunity to emphasize the significance of local organizations for pharmacy professionals. CAPA membership offers a dynamic platform for collaboration, learning, professional promotion and community service. To enhance our association, I challenge everyone to: 

1. Actively contribute to our growth by recruiting peers and others.
2. Get involved in our initiatives and activities.
3. Let me know how the association can better serve its membership.

Congratulations to our 2023 CAPA Scholarship Winners

Marisa Dallas is a P2 at the University of Michigan. She is a Phi Delta Chi Pharmacy Fraternity member, has worked as a compounding intern at The Village Pharmacy and Compounding in Bloomfield Hills and holds a master’s degree in bioethics from Columbia University. You may have attended Dallas’ informational CAPA continuing education (CE) presentation on bioethics in May 2023. After graduation, Marisa plans to pursue an ambulatory care residency while staying involved in research and the bioethics community. She also plans to return to the Lansing area to continue to serve the community that has supported her throughout her educational journey.

Kenza Sumbal is a P3 at Ferris State University. She is an active member of the Arab American Pharmacist Association, Diversity in Pharmacy, and National Community Oncology Dispensing Association, in which she served as the Director of Finances from 2022 to 2023. She is currently an intern at Walmart pharmacy. Kenza envisions herself working in an ambulatory care setting in 5-10 years, making a difference in my patients' lives, doing volunteer work for refugee camps, and working underprivileged areas, to provide care to people who do not have financial resources.

This year’s scholarship application can be found on the CAPA website in summer 2024 and is due November 1, 2024. P1-P4 pharmacy students in the quad county area are eligible to apply as long they were not awarded the CAPA scholarship the previous year.

CAPA at ACE

The Michigan Pharmacists Association (MPA) hosted its Annual Convention & Exposition (ACE) the weekend of February 23-25, 2024. Many CAPA members attended and participated in continuing education activities, social and networking events, and the House of Delegates (HOD) session. CAPA strives to submit at least one HOD resolution each year to help shape policies that advocate for the pharmacy profession. This year, CAPA’s requirement for Board of Pharmacy inspectors to undergo yearly training in USP Compounding standards passed as written with much support from the house! 

Special thanks to our representatives Jeff Ackerman, Peggy Malovrh, Sue Arens, Faith Allen and Evelynne Smith for representing CAPA and accepting our Distinguished Local Chapter and Local Association Achievement Award! 

CAPA at ACE: From left, Sue Feher, Peggy Malovrh, Jeff Ackerman and Faith Allen.

OFFICERS

PRESIDENT | Kyle Schmidt | 616-685-6675 | Mercy Health St. Mary's, Grand Rapids

PRESIDENT-ELECT | Stacy Brousseau | 269-341-7407 | Bronson Methodist Hospital, Kalamazoo

IMMEDIATE PAST PRESIDENT | Michelle Dehoorne | 313-343-6381 | Ascension, Detroit

TREASURER | Marc Guzzardo | 810-606-6095 | Ascension, Detroit

EXECUTIVE VICE PRESIDENT | Edward Szandzik | 313-587-6279 | Detroit

DIRECTORS

Diana Kostoff | 313-725-7925 | Henry Ford, Detroit

Nada Farhat | nmhammou@med.umich.edu | Michigan Medicine, Ann Arbor

Julie Schmidt | 269-341-7999 | Bronson Methodist Hospital, Kalamazoo

Amber Lanae Martirosov | 313-916-3494 | Wayne State University

REGIONAL SOCIETY REPRESENTATIVES 

CENTRAL | Tim Ekola | 734-845-3418 | VA Ann Arbor Healthcare System

NORTHERN | Miranda Maitland | mirandapmaitland@gmail.com | My Michigan Medical Center, Sault Ste. Marie

SOUTHEASTERN | Farzad Daneshvar | 248-910-2222 | AstraZeneca

WESTERN | Ben Pontefract | bpontefract@gmail.com | Ferris State University, Big Rapids

MANAGING EDITOR | Ryan Weiss | (517) 377-0232 | Michigan Pharmacists Association, Lansing

The MSHP Monitor is a publication of the Michigan Society of Health-System Pharmacists, published as a service to its members.

Michigan Society of Health-System Pharmacists - An Affiliated Chapter of the American Society of Health-System Pharmacists and a Practice Section of the Michigan Pharmacists Association